The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression

Br J Clin Pharmacol. 2011 Sep;72(3):514-7. doi: 10.1111/j.1365-2125.2011.04008.x.

Abstract

Aim: To evaluate whether selective serotonin re-uptake inhibitor (SSRI) exposure influences the risk of myocardial infarction (MI) in patients with depression.

Methods: This study included 693 patients with MI (cases) and 2772 controls. Conditional logistic regression was used to calculate the odds ratio (OR).

Results: SSRI exposure may be associated with a reduced MI risk (OR = 0.77, 95% CI 0.57, 1.03). However, reduced risk was only observed with longer term use (OR = 0.73, 95% CI 0.53, 1.00) and not with shorter term use (OR = 1.15, 95% CI: 0.65, 2.05).

Conclusions: Only longer term use of SSRIs was associated with reduced MI risk, suggesting that other mechanisms, besides an acute anti-platelet effect, may reduce MI risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antidepressive Agents, Second-Generation / adverse effects*
  • Case-Control Studies
  • Cohort Studies
  • Depressive Disorder / drug therapy*
  • Female
  • Humans
  • Logistic Models
  • Male
  • Myocardial Infarction / chemically induced*
  • Odds Ratio
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects*

Substances

  • Antidepressive Agents, Second-Generation
  • Serotonin Uptake Inhibitors